Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients.
about
Adjunctive steroid therapy for managing pulmonary tuberculosisClinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registryNovel adjunctive therapies for the treatment of tuberculosisPractical aspects of the management of pericardial disease.Tuberculosis pericarditis with cardiac tamponade: management in the resource-limited setting.HIV infection is associated with a lower incidence of constriction in presumed tuberculous pericarditis: a prospective observational studyHeart Disease in Patients with HIV/AIDS-An Emerging Clinical Problem.MCL Plays an Anti-Inflammatory Role in Mycobacterium tuberculosis-Induced Immune Response by Inhibiting NF-κB and NLRP3 Inflammasome Activation.HIV: treating tuberculosis.Randomized placebo-controlled trial of prednisone for paradoxical tuberculosis-associated immune reconstitution inflammatory syndromeHIV patients treated with low-dose prednisolone exhibit lower immune activation than untreated patientsAdjuvant corticosteroids for tuberculous pericarditis: promising, but not proven.Pericardiectomy for chronic constrictive tuberculous pericarditis: risks and predictors of survival.Predictive factors for unfavorable outcomes of tuberculous pericarditis in human immunodeficiency virus-uninfected patients in an intermediate tuberculosis burden country.Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndromeInflammatory status hepatic enzymes and serum creatinine in HIV-, HIV+ and HIV-TB co-infected adult Central Africans.HIV-1 and the immune response to TB.Prednisolone and Mycobacterium indicus pranii in tuberculous pericarditisNovel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistanceDiagnosis and management of TB in children: an update.Tuberculous pericarditis with and without HIV.Management of the immune reconstitution inflammatory syndrome.Host-Directed Therapies for Tuberculosis.Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.Steroids: a promising drug for abdominal tuberculosis?Rapid diagnosis of tuberculous pericarditis by ELISPOT assay.The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV.Interventions for treating tuberculous pericarditis
P2860
Q24188019-6C9531DA-5069-4A23-BB4E-27CB21C0FA0AQ25257355-631228D9-3CAE-4208-96AC-AF71B9D2A89EQ26829957-ADB5055E-84B2-49CF-88C2-DC12579D11DBQ30478750-C8540817-DF3E-4884-B11F-64C536016FD6Q30497443-73AA23B1-C29C-44AA-9223-DA2BC0E9ED8CQ33340254-ED4FA980-312D-49C1-909C-53489AA8C53CQ33587954-D83FE306-A013-4E7F-AC15-30C261FDD3ECQ33795068-6FB7AB16-B6C0-4792-8AFD-0A1DFDF50F85Q33950001-AEFBABE9-5B23-4DE1-8619-5BBBD79D794AQ34130659-7C12227E-7EDE-4840-BCC1-F1747DD7B2AFQ34134411-627D8334-F72B-4072-88B3-4514401936A3Q35191048-0708B06C-5C97-4796-96C7-E156B85A5BDDQ35985864-D16A5AEC-3826-4CE4-8F36-47089863A564Q36206991-E87C3365-448B-45A0-88E6-EF855E473D96Q36238260-7B37640B-6BCD-407B-8A17-8ACCB8F12EADQ36429638-D6EF3A51-B577-4451-89DD-8879FFAEAA11Q36815449-D34E2BC5-4B14-462B-B53B-0AB52F41AD34Q37018268-878ADDBD-591C-42F1-AB76-83CA54155EACQ37331456-EDAEBEC9-03DF-45DB-AAED-9D0E625BC2D4Q37960565-8A30E95C-C51B-40D5-AF14-AF2B12F6BF96Q37994619-6F90A52E-1B94-4659-B9DB-59F92997E073Q38023242-7525E8B0-E8AE-4743-BB92-15E758FA4759Q38489473-11FF61CD-3415-478B-83DA-AE778FA43013Q40542672-D22F1FA0-84A0-4555-8173-A60C37749727Q42728375-07726C49-0F24-4F4A-BEE3-CC5EA1D3D2EAQ43123694-F2A414F3-56BB-45D9-8F76-4DD0011B1ED4Q46607880-B3E76F16-2FA7-4B41-A0E3-52615DA6FB66Q56930268-41638039-30CD-4B76-B8B9-D51158331984
P2860
Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
2000年论文
@zh
2000年论文
@zh-cn
name
Double blind randomised placeb ...... in HIV seropositive patients.
@ast
Double blind randomised placeb ...... in HIV seropositive patients.
@en
type
label
Double blind randomised placeb ...... in HIV seropositive patients.
@ast
Double blind randomised placeb ...... in HIV seropositive patients.
@en
prefLabel
Double blind randomised placeb ...... in HIV seropositive patients.
@ast
Double blind randomised placeb ...... in HIV seropositive patients.
@en
P2093
P2860
P356
P1433
P1476
Double blind randomised placeb ...... in HIV seropositive patients.
@en
P2093
P2860
P304
P356
10.1136/HEART.84.2.183
P407
P50
P577
2000-08-01T00:00:00Z